These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31402495)

  • 1. Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.
    Young RM; Phelan JD; Wilson WH; Staudt LM
    Immunol Rev; 2019 Sep; 291(1):190-213. PubMed ID: 31402495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
    Phelan JD; Young RM; Webster DE; Roulland S; Wright GW; Kasbekar M; Shaffer AL; Ceribelli M; Wang JQ; Schmitz R; Nakagawa M; Bachy E; Huang DW; Ji Y; Chen L; Yang Y; Zhao H; Yu X; Xu W; Palisoc MM; Valadez RR; Davies-Hill T; Wilson WH; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Rodriguez FJ; Estephan F; Holdhoff M; Kruhlak MJ; Hewitt SM; Thomas CJ; Pittaluga S; Oellerich T; Staudt LM
    Nature; 2018 Aug; 560(7718):387-391. PubMed ID: 29925955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell receptor signaling as a driver of lymphoma development and evolution.
    Niemann CU; Wiestner A
    Semin Cancer Biol; 2013 Dec; 23(6):410-21. PubMed ID: 24060900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells.
    Zhu F; Guo H; Bates PD; Zhang S; Zhang H; Nomie KJ; Li Y; Lu L; Seibold KR; Wang F; Rumball I; Cameron H; Hoang NM; Yang DT; Xu W; Zhang L; Wang M; Capitini CM; Rui L
    Leukemia; 2019 Dec; 33(12):2898-2911. PubMed ID: 31123343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.
    Havranek O; Xu J; Köhrer S; Wang Z; Becker L; Comer JM; Henderson J; Ma W; Man Chun Ma J; Westin JR; Ghosh D; Shinners N; Sun L; Yi AF; Karri AR; Burger JA; Zal T; Davis RE
    Blood; 2017 Aug; 130(8):995-1006. PubMed ID: 28646116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma.
    Dunleavy K; Erdmann T; Lenz G
    Cancer Treat Rev; 2018 Apr; 65():41-46. PubMed ID: 29549872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
    Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
    Wilson WH; Young RM; Schmitz R; Yang Y; Pittaluga S; Wright G; Lih CJ; Williams PM; Shaffer AL; Gerecitano J; de Vos S; Goy A; Kenkre VP; Barr PM; Blum KA; Shustov A; Advani R; Fowler NH; Vose JM; Elstrom RL; Habermann TM; Barrientos JC; McGreivy J; Fardis M; Chang BY; Clow F; Munneke B; Moussa D; Beaupre DM; Staudt LM
    Nat Med; 2015 Aug; 21(8):922-6. PubMed ID: 26193343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
    Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
    J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma in Southeast Asian cohort: expression patterns of B-cell receptor (BCR) repertoire and its linkage with molecular subtypes and response to R-CHOP therapy.
    Masir N; Akhter A; Roshan TM; Florence CS; Abdul-Rahman F; Tumian NR; Kean-Chang P; Elyamany G; Shabani-Rad MT; Mansoor A
    J Clin Pathol; 2019 Sep; 72(9):630-635. PubMed ID: 31189540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14.
    Choi J; Phelan JD; Wright GW; Häupl B; Huang DW; Shaffer AL; Young RM; Wang Z; Zhao H; Yu X; Oellerich T; Staudt LM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6092-6102. PubMed ID: 32127472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular deregulation of signaling in lymphoid tumors.
    Spina V; Martuscelli L; Rossi D
    Eur J Haematol; 2015 Oct; 95(4):257-69. PubMed ID: 25881749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell receptor signaling in diffuse large B-cell lymphoma.
    Young RM; Shaffer AL; Phelan JD; Staudt LM
    Semin Hematol; 2015 Apr; 52(2):77-85. PubMed ID: 25805587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin.
    Rink JS; Yang S; Cen O; Taxter T; McMahon KM; Misener S; Behdad A; Longnecker R; Gordon LI; Thaxton CS
    Mol Pharm; 2017 Nov; 14(11):4042-4051. PubMed ID: 28933554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell receptor signaling in the pathogenesis of lymphoid malignancies.
    Bojarczuk K; Bobrowicz M; Dwojak M; Miazek N; Zapala P; Bunes A; Siernicka M; Rozanska M; Winiarska M
    Blood Cells Mol Dis; 2015 Oct; 55(3):255-65. PubMed ID: 26227856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data.
    Schrader A; Meyer K; Walther N; Stolz A; Feist M; Hand E; von Bonin F; Evers M; Kohler C; Shirneshan K; Vockerodt M; Klapper W; Szczepanowski M; Murray PG; Bastians H; Trümper L; Spang R; Kube D
    Oncotarget; 2016 Jul; 7(30):47061-47081. PubMed ID: 27166259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma.
    Xu W; Berning P; Lenz G
    Blood; 2021 Sep; 138(13):1110-1119. PubMed ID: 34320160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.
    Buchner M; Müschen M
    Curr Opin Hematol; 2014 Jul; 21(4):341-9. PubMed ID: 24811161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC Protein-positive Diffuse Large B-Cell Lymphoma Features an Activated B-Cell Receptor Signal Pathway.
    Wang WG; Jiang XN; Liu ZB; Zhou XY; Li XQ
    Am J Surg Pathol; 2017 Apr; 41(4):541-549. PubMed ID: 28291124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.